期刊文献+

树突状细胞对肿瘤特异性CTL体外激发、扩增及功能的作用研究 被引量:1

The Effect of Dendritic Cells on the Proliferation and Function of Tumor Specific Cytotoxic T Lymphocyte
下载PDF
导出
摘要 目的 研究凋亡肿瘤细胞负载的DCs联合细胞因子对T细胞体外激发、扩增及功能的诱导作用。方法 人B淋巴瘤细胞株Raji经顺铂 (DDP)诱导凋亡 ,体外共育法负载DCs,DCs和T细胞体外共培养观察DCs对T细胞的效应 ,采用免疫荧光标记和流式细胞仪分析T细胞表型 :ELISA法检测细胞培养上清中细胞因子IFN -γ、IL - 10的含量 ;溶血实验检测细胞毒性T细胞 (CTL)产生穿孔素的能力 ;体外肿瘤杀伤实验分析CTL的特异性肿瘤杀伤作用。结果 凋亡肿瘤细胞负载联合CD4 0激发的DCs能有效地激发自体T细胞的体外扩增并诱导具有较特异杀伤肿瘤细胞作用的CTL。结论 凋亡肿瘤细胞负载的DCs在CD4 0信号的作用下对自体T细胞具有较强的激发和扩增效应 ,所获得的CTL对肿瘤细胞具有较特异的杀伤作用。 Objective To investigate the effect of the apoptotic tumor cells-loaded dendritic cells associated with different cytokines on the proliferation and biological function of autologous T cells in vitro. Methods Human malignant B cell lymphoma cell line Raji was induced apoptosis by treating with 0.5mg DDP/10 7 cell/ml for 3-4h.Then the apoptotic tumor cells were used to pulse DCs.Coculturing assay of DCs and T cells was set up to investigate the effect of DCs on Tcells.Phenotypes of CTL were analyzed by flow cytometry,the concentration of IFN-γ and IL-10 in supernatant of CTL was deternined by ELISA;the ability of CTL producing perforin was measured by homolysis method;T-cell cytotoxicity was measured by MTT assay. Results The apoptotic tumor cells-pulsed DCs stimulated by agonistic anti-CD40 mAb were potent to stimulate autologous T lymphocytes proliferation and also showed a specific and effective toxicity to allogenic tumor cells in vitro. Conclusion The apoptotic-tumor cells loaded DCs have efficient ability to stimulate the T cells to proliferate and the CTLs obtained have high anti-tumor specific activities in vitro.lt may be of great value in the adoptive treatment of tumor.
出处 《苏州大学学报(医学版)》 CAS 2004年第4期475-478,共4页 Suzhou University Journal of Medical Science
基金 苏州大学学生科研基金 苏州大学青年教师基金资助
关键词 树突状细胞 细胞毒性T细胞 肿瘤免疫 CD40 Dendritic cell(DC) cytotoxic T lymphocyte(CTL) tumor immunology CD40
  • 相关文献

参考文献10

  • 1Ang Y,Kelly CG,Karttunen JT,et al.CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines[J].Immunity,2001,15:971-983.
  • 2Cao X,Zhang W,He L.Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity[J].J Immunother,1998,161:6238-6244.
  • 3Idmann TA,Dubois S,Tagaya Y,et al Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes:implications for immunotherapy[J].Immunity,2001,14:105-110.
  • 4Sprinxl G M Kacani L,Schrott fischer A,Romani N.Dendritic cell vaccines for cancer therapy[J].Cancer treatment reviews,2001,27:247-255.
  • 5Zhou ZH,Wang JF,Zhang XG,et al.An agonist anti-human CD40 monoclonal antibody that induces dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line[J].Hybridona.1999,18(6):471-478.
  • 6Mackey MF,Brath RJ,Noelle RJ,et al.The role of CD40/CD154 interactions in the priming,differentiation and effector function of helper and cytotoxic T cells[J]. J Leuoc Biol,1998,63:418-428.
  • 7Steinman RM.The dendritic cell system and its role in immunogenicity[J].Annu Rev Immunol,1991,9:271-296.
  • 8Ella M,Scheidegger D,Palmer Lehmann K,et al.Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity[J].T-T help via APC activation[J]. J Exp Med,1996,184:747-752.
  • 9Dallal R,Lotze M.The dendritic cell and huma cancer vaccines[J].Cuin Opin Immunol,2000,12:583-588.
  • 10Nouri Shiazi M,Banchereau J,Fay J,et al.Dendritic cell based tumor vaccines[J].Immunology Letters,2000,74:5-10.

同被引文献12

  • 1陈志强,李惠芳,张英,朱平.肿瘤患者T细胞克隆性增殖与预后的分析[J].肿瘤防治研究,2004,31(8):471-473. 被引量:1
  • 2Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation [ J ]. Cell, 2011, 144 (5) : 646 - 674.
  • 3Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis [ J ].Nat Rev Cancer, 2004, 4(1) : 71 -78.
  • 4Colotta F, Allavena P, Sica A, et al. Cancer-related in- flammation, the seventh hallmark of cancer : links to genetic instability[ J]. Carcinogenesis, 2009,30(7) : 1073 - 1081.
  • 5Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting[J]. Annu Rev Immunol, 2004, 22: 329-360.
  • 6Disis ML. Immune regulation of cancer[J]. J Clin Oncol, 2010, 28(29) : 4531 -4538.
  • 7Pages F, Kirilovsky A, Mlecnik B, et al. In situ cytotoxic and memory T cells predict outcome in patients with early- stage colorectal cancer[J]. J Clin Oncol, 2009, 27(35) : 5944 - 5951.
  • 8Clemente CG, Mihm MC, Bufalino R, et al. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma[ J ]. Cancer, 1996, 77(7) : 1303 - 1310.
  • 9Gajewski TF, Meng Y, Blank C, et al. Immune resistance orchestrated by the tumor microenvironment [ J ]. Immunol Rev, 2006, 213(1): 131 -145.
  • 10Galon J, Costes A, Sanchez-Cabo F, et al. Type, densi- ty, and location of immune cells within human colorectal tumors predict clinical outcome [ J ]. Science, 2006, 313 (5795) : 1960 - 1964.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部